ORAPRED ODT prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and ORAPRED ODTside effects.

Orapred contains prednisolone which works by reducing inflammation. How much and how long you take Orapred ODT will depend on your weight and your condition. Some patients may only need to take this ...

Mylan announced the launch of Prednisolone Sodium Phosphate Orally Disintegrating Tablets, the generic of Shionogi's Orapred ODT.

BioMarin, which will retain the commercial rights to Orapred outside of North America, expects to launch Orapred ODT during the second half of 2006. Shares were trading up $1.84 to $14.29.

Orapred ODT, an asthma treatment, is expected to commercially launch in the United States during the second half of 2006.

Mylan (MYL) announced that it has entered into a settlement agreement with Shionogi and CIMA Labs that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating ...

BioMarin Pharmaceutical Inc. (BMRN) and Alliant Pharmaceuticals Inc. said the Food and Drug Administration has granted marketing approval for Orapred ODT, the first orally disintegrating tablet ...

The agency scored eight account wins, including Impax Pharmaceuticals (for a Parkinson’s disease drug), Merz Pharmaceuticals (for the global launch of an Alzheimer’s treatment) and Shionogi (Moxatag, ...

Orapred ODT had U.S. sales of approximately $28 million for the 12 months ending Sept. 30, 2010, according to IMS Health.

BioMarin Pharmaceutical Inc. said Monday that its asthma drug Orapred ODT went on sale in the United States. The drug, the first orally disintegrating prednisolone tablet approved by U.S ...

was higher following word that Orapred ODT, an orally disintegrating tablet form of prednisolone, is now commercially available in the U.S. BioMarin's shares were up 1% to $15.85.